From last years annual report they stated they had started the clinical trial in September 2023 and were forecasting submission Q4 calendar year 2023. Shows management's inexperience with guiding a business through the FDA process OR there are issues not being communicated.
- Forums
- ASX - By Stock
- PCK
- Ann: Annual Report to shareholders
PCK
painchek ltd
Add to My Watchlist
2.94%
!
3.5¢

Ann: Annual Report to shareholders, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.5¢ |
Change
0.001(2.94%) |
Mkt cap ! $64.47M |
Open | High | Low | Value | Volume |
3.4¢ | 3.5¢ | 3.4¢ | $9.476K | 271.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 797305 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 74114 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 797305 | 0.034 |
9 | 1269379 | 0.033 |
5 | 657100 | 0.032 |
8 | 324958 | 0.031 |
6 | 1220667 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 74114 | 2 |
0.036 | 77354 | 1 |
0.037 | 159000 | 1 |
0.038 | 41500 | 1 |
0.039 | 25000 | 1 |
Last trade - 10.38am 24/06/2025 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |